MS in the Media - 12 July 2019
6 - 12 July 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Poor experiences require national plan for neurology
People in England with neurological conditions are facing long waiting times, poor access to specialists and a lack of personalised care, according to a report/survey by the Neurological Alliance. They call for a National Plan for Neurology and suggest people write to their MPs
Source: Neurological Alliance
MS Trust link: Call for national neurology plan following largest ever survey of people with neurological conditions - MS Trust news item
Regular standing helps symptoms
Regular standing in a frame helps people with advanced MS with balance and movement, according to UK research. The story includes a man who says using the frame helped him be able to walk his daughter down the aisle at her wedding
Source: BBC
MS Trust link: Posture and MS
Stem cell successes
Two women have both done well after treatment with stem cells transplants.
Source: Daily Mail
MS Trust link: Stem cell treatment
Breath test may spot MS
Researchers are exploring whether analysing molecules that people exhale might lead to a potential breath test for diagnosing MS.
Source: MS News Today
MS Trust link: MS research updates
Gadolinium doesn't affect health
The contrast agent used in MRI scans does accumulate in the brain but doesn't seem to affect health over the first five years with MS, according to US research
Source: University of Buffalo
MS Trust link: Magnetic resonance imaging (MRI)
Opicinumab trial unsuccessful
A trial comparing people taking Avonex (interferon beta 1a) with or without opicinumab (anti-LINGO-1) failed to show an effect on walking and upper limb coordination. Another study, already fully recruited, is starting focussing on people within 20 years of onset - a subgroup who seemed to do best in the original trial.
Source: National MS Society (USA)
MS Trust link: Drugs in development
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
